Detected ·
Cayuga Biotech
——
Gopher Angels announced a follow-on investment in Cayuga Biotech, a biotech developing CAY001, a first-in-class hemostatic drug for life-threatening hemorrhage, now in Phase 1 trials.
- Website
- www.cayugabiotech.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-09-23 16:09:46 UTC
- Signal ID
- 9f0b60ce-abc8-4dc6-b5fd-304ecaf9597d
As the API returns it
{
"id": "9f0b60ce-abc8-4dc6-b5fd-304ecaf9597d",
"created_at": "2026-09-23T16:09:46.336530Z",
"company_name": "Cayuga Biotech",
"company_website_url": "www.cayugabiotech.com",
"company_linkedin_url": "https://www.linkedin.com/company/cayuga-biotech",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Gopher Angels announced a follow-on investment in Cayuga Biotech, a biotech developing CAY001, a first-in-class hemostatic drug for life-threatening hemorrhage, now in Phase 1 trials.*"
}